0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Kidney Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Kidney Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 244 Pages
  • China
From
EUR$4,000USDGBP
Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019

  • Report
  • September 2019
  • 29 Pages
  • Global
EUR$10,000USDGBP
Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 Pages
  • Global
EUR$10,000USDGBP
Inlyta (axitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Inlyta (axitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 20 Pages
  • Global
EUR$10,000USDGBP
Sutent (sunitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Sutent (sunitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 19 Pages
  • Global
EUR$10,000USDGBP
Tarceva - Product Thumbnail Image

Tarceva

  • Report
  • August 2018
  • 25 Pages
  • Global
From
EUR$10,000USDGBP
Votrient - API Insight, 2022 - Product Thumbnail Image

Votrient - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Nexavar - API Insight, 2022 - Product Thumbnail Image

Nexavar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Sutent - API Insight, 2022 - Product Thumbnail Image

Sutent - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Tarceva - API Insight, 2022 - Product Thumbnail Image

Tarceva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Exeter Erlotinib hydrochloride tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Exeter Erlotinib hydrochloride tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 93 Pages
  • Global
From
EUR$3,970USDGBP
Renal Cell Carcinoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Renal Cell Carcinoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 93 Pages
  • Global
From
EUR$3,970USDGBP
Everolimus Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Everolimus Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 71 Pages
  • Global
From
EUR$3,970USDGBP
Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 92 Pages
  • Global
From
EUR$3,970USDGBP
Sorafenib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Sorafenib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 107 Pages
  • Global
From
EUR$3,970USDGBP
Axitinib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Axitinib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 112 Pages
  • Global
From
EUR$3,970USDGBP
Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 83 Pages
  • Global
From
EUR$3,970USDGBP
Capecitabine Fumarate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Capecitabine Fumarate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 114 Pages
  • Global
From
EUR$3,970USDGBP
Erlotinib hydrochloride Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Erlotinib hydrochloride Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • April 2023
  • 108 Pages
  • Global
From
EUR$3,970USDGBP
Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 99 Pages
  • Global
From
EUR$3,970USDGBP
Loading Indicator

The Kidney Cancer Drugs market is a subset of the pharmaceutical industry that focuses on the development and sale of drugs used to treat kidney cancer. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce the spread of cancer to other parts of the body. Common treatments include chemotherapy, targeted therapy, immunotherapy, and surgery. The market is highly competitive, with many companies vying for market share. Major players include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and AstraZeneca. These companies are constantly researching and developing new drugs to improve the treatment of kidney cancer. Additionally, many smaller companies are also involved in the market, offering innovative treatments and therapies. Overall, the Kidney Cancer Drugs market is an important part of the pharmaceutical industry, providing treatments and therapies to improve the lives of those affected by kidney cancer. Show Less Read more